[HTML version][PDF version][CIF][3d view][Structure Factors][CIF check Report][Issue contents]  [Buy article online]

[Contents scheme]

Acta Cryst. (2005). E61, m1915-m1917  [ doi:10.1107/S1600536805027418 ]

Bis[[mu]-2-(1-butylbenzimidazol-2-yl)phenolato]-1[kappa]N3:2[kappa]O;1[kappa]O:2[kappa]N3-bis{[2-(1-butylbenzimidazol-2-yl)phenolato-[kappa]2N3,O]zinc(II)} 2-(1-butylbenzimidazol-2-yl)phenol disolvate

Y.-P. Tong, Y.-W. Lin and S. W. Ng

Abstract: The centrosymmetric dinuclear title compound, [Zn2(C17H17N2O)4]·2C17H18N2O, has one 2-(1-butylbenzimidazol-2-yl)phenolate acting as a chelating ligand and the other as a bridging ligand, conferring a tetrahedral geometry on the Zn atom. The uncoordinated 2-(1-butylbenzimidazol-2-yl)phenol molecule interacts with the O atom of the chelating anion through a hydrogen bond.

Online 7 September 2005


Copyright © International Union of Crystallography
IUCr Webmaster